Clinical trials: Central Auditory Processing Disorder, open to volunteers
Central Auditory Processing Disorder, Hearing Impaired (Partially)
A Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
The goal of this clinical trial is to determine the efficacy of Clemastine Fumarate in the presence of engineered sound to treat age-related central auditory processing disorder (CAPD).
- Conditions
- Central Auditory Processing Disorder, Hearing Impaired (Partially), Hearing, Hearing Abnormality
- Trial name
- CAPD-LOOT (NCT07304024)
- Testing
- Clemastine Fumarate Combined With Engineered Sound, Clemastine Fumarate Combined With Pink Noise
- Where
- United States
- Volunteers
- 344 people
- Sponsor
- University of Colorado, Denver
Central Auditory Processing Disorder, Autism Spectrum Disorder
Sleep and Central Auditory Processing Disorder in Autism Spectrum Disorder
The proposed study aims to understand poor sleep as a possible cause to CAPD in children and adolescents with ASD (ASD+) compared to ASD youth without CAPD (ASD-), using both caregiver-report and objective clinician administered…
- Conditions
- Central Auditory Processing Disorder, Autism Spectrum Disorder, Sleep Disturbance
- Trial name
- ASD (NCT06059352)
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- Loma Linda University